CJC-1295 is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
CJC-1295 is being researched for anti-aging applications. CJC-1295 binds to GHRH receptors on anterior pituitary somatotrophs, stimulating growth hormone synthesis and pulsatile secretion through the cAMP-PKA signaling cascade. The 'no DAC' version has a sho. Common dosages for this use range from 100-300 mcg 1-3 times daily, typically before bed.
Can CJC-1295 Help With Anti-Aging?
CJC-1295 (CJC-1295 (Modified GRF 1-29)) is being researched for anti-aging applications based on its mechanism as a Growth Hormone Releasing Hormone (GHRH) analog.
CJC-1295 binds to GHRH receptors on anterior pituitary somatotrophs, stimulating growth hormone synthesis and pulsatile secretion through the cAMP-PKA signaling cascade. The 'no DAC' version has a shorter half-life, resulting in more natural GH pulses that mimic the body's endogenous rhythm rather than creating sustained supraphysiological levels.
What Does the Research Show for CJC-1295 and Anti-Aging?
Clinical research demonstrates significant increases in GH and IGF-1 levels in human subjects. Studies show improved body composition with increased lean mass and reduced body fat, particularly when combined with GHRP peptides like Ipamorelin.
The relevance to anti-aging specifically comes from CJC-1295's effects on increased growth hormone secretion, improved body composition, better sleep quality, enhanced recovery, anti-aging effects.
What Protocol Is Used for Anti-Aging?
For anti-aging applications, the standard CJC-1295 protocol is 100-300 mcg administered 1-3 times daily, typically before bed via subcutaneous injection for 8-12 weeks, often paired with Ipamorelin.
Some researchers adjust dosing based on the specific anti-aging application — see our CJC-1295 dosage guide for full protocol details.
Can Stacking Improve Anti-Aging Results?
The gold standard stack is CJC-1295 + Ipamorelin — GHRH + GHRP together produce GH pulses far greater than either alone, through synergistic pituitary stimulation via two distinct receptor pathways.
What Side Effects Apply to Anti-Aging Use?
Possible water retention, tingling/numbness in hands (carpal tunnel-like), increased appetite, mild headache, and flushing at injection site. Effects are dose-dependent and typically subside with continued use.
Side effects are generally consistent regardless of the specific application. See our CJC-1295 side effects guide for details.
Calculate Your CJC-1295 Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for CJC-1295.
Open Calculator →Bottom Line: CJC-1295 for Anti-Aging
CJC-1295 shows preliminary research potential for anti-aging. Standard protocols (100-300 mcg, 1-3 times daily, typically before bed, 8-12 weeks, often paired with Ipamorelin) apply.
Source from COA-tested vendors and maintain consistent dosing for the full cycle duration.
Complete Guide
CJC-1295 : Benefits, Dosage, Side Effects & Research
Related Reading
- CJC-1295 Dosage Guide
- CJC-1295 Benefits
- CJC-1295 Side Effects
- CJC-1295 Stacking Guide
- CJC-1295 Cycle Guide
- CJC-1295 Research
Research-Grade Sourcing
If you're going to research CJC-1295, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is CJC-1295?
CJC-1295 (CJC-1295 (Modified GRF 1-29)) is a Growth Hormone Releasing Hormone (GHRH) analog. Synthetic peptide analog of GHRH (first 29 amino acids) with four amino acid substitutions for enhanced stability. It is researched for increased growth hormone secretion, improved body composition, better sleep quality, enhanced recovery, anti-aging effects.
What is the recommended CJC-1295 dosage?
Common dosages: 100-300 mcg administered 1-3 times daily, typically before bed via subcutaneous injection. Cycle length: 8-12 weeks, often paired with Ipamorelin. Half-life: ~30 minutes (no DAC), ~8 days (with DAC). Use our peptide calculator for exact reconstitution math.
What are the side effects of CJC-1295?
Possible water retention, tingling/numbness in hands (carpal tunnel-like), increased appetite, mild headache, and flushing at injection site. Effects are dose-dependent and typically subside with continued use.
Is CJC-1295 safe?
CJC-1295 has shown a preliminary safety profile in research. Not FDA-approved. Research chemical status. Banned by WADA. All research should follow appropriate safety protocols.